AAP
PRVA icon

Arax Advisory Partners’s Privia Health PRVA Stock Holding History

Arax Advisory Partners’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$56.9K Buy
2,212
+2,105
+1,967% +$48.8K ﹤0.01% 3172
2026
Q1 		$2.2K Buy
107
+97
+970% +$2.19K ﹤0.01% 3084
2025
Q4 		$237 Sell
10
-2,354
-100% -$57.3K ﹤0.01% 3694
2025
Q3 		$58.9K Buy
2,364
+2,270
+2,415% +$48.9K ﹤0.01% 1749
2025
Q2 		$2.16K Buy
94
+60
+176% +$1.39K ﹤0.01% 2547
2025
Q1 		$764 Buy
+34
New +$790 ﹤0.01% 2405
2024
Q4 		– Sell
-69
Closed -$1.26K – 2677
2024
Q3 		$1.26K Hold
69
– – ﹤0.01% 2191
2024
Q2 		$1.2K Buy
+69
New +$1.22K ﹤0.01% 2119

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Arax Advisory Partners's PRVA Position: Q2 2026 in Review

Arax Advisory Partners increased its Privia Health (PRVA) stake by 1,967% in Q2 2026, buying an estimated $48.8K and bringing the position to 2,212 shares worth $56.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3172.

Arax Advisory Partners first reported a position in PRVA in Q2 2024 and has held it in 8 quarters since. The position peaked at $58.9K in Q3 2025. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Arax Advisory Partners held 2,212 shares of Privia Health worth $56.9K as of Q2 2026.
  • Arax Advisory Partners bought 2,105 Privia Health shares in Q2 2026, an estimated $48.8K.
  • Privia Health made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3172 holding.
  • Arax Advisory Partners first reported a position in Privia Health in Q2 2024 and has held it in 8 quarters since.
  • Arax Advisory Partners's Privia Health position peaked at $58.9K in Q3 2025.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.